Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AMPE · as of Jun 8, 2026
Activity summary
Buy transactions
8
P-Purchase only
Sell transactions
7
12 Months
Buy/Sell ratio
1.14
Buy/Sell (by trades)
Overall sentiment
Ampio Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
AMPE insider buying and selling by quarter
AMPE insider selling · AMPE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
AMPE executive sell shares · AMPE board member insider trading · AMPE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 9, 2023 | BUCHI J KEVIN Director | Purchase | 21,858 | $6K | Form 4 |
| Jun 8, 2023 | BUCHI J KEVIN Director | Purchase | 25,000 | $7K | Form 4 |
| May 24, 2023 | MARTINO MICHAEL A CEO · Director | Purchase | 76,890 | $22K | Form 4 |
| May 16, 2023 | BUCHI J KEVIN Director | Purchase | 32,534 | $9K | Form 4 |
| May 15, 2023 | BUCHI J KEVIN Director | Purchase | 44,026 | $11K | Form 4 |
| May 12, 2023 | BUCHI J KEVIN Director | Purchase | 23,440 | $6K | Form 4 |
| May 12, 2023 | Stevens David R Director | Purchase | 45,000 | $10K | Form 4 |
| May 11, 2023 | Stevens David R Director | Purchase | 25,000 | $5K | Form 4 |
| May 11, 2023 | Stevens David R Director | Purchase | 25,000 | $6K | Form 4 |
| Jan 1, 2022 | STOKELY DAN CFO | Other | 22,914 | $13K | Form 4 |
| Jan 1, 2022 | Cherevka Holli PRESIDENT AND COO | Other | 47,200 | $27K | Form 4 |
| Jan 1, 2022 | MACALUSO MICHAEL Director | Other | 68,400 | $39K | Form 4 |
| Oct 27, 2021 | STOKELY DAN CFO | Other | 28,127 | $46K | Form 4 |
| Oct 27, 2021 | Cherevka Holli PRESIDENT AND COO | Other | 41,980 | $69K | Form 4 |
| Oct 27, 2021 | MACALUSO MICHAEL CEO · Director | Other | 43,470 | $71K | Form 4 |
| Oct 11, 2021 | MACALUSO MICHAEL CEO · Director | Award | 950,000 | — | Form 4 |
| Oct 11, 2021 | STOKELY DAN CFO | Award | 335,000 | — | Form 4 |
| Oct 11, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Award | 500,000 | — | Form 4 |
| Jun 25, 2021 | STOKELY DAN CFO | Option | 22,500 | $10K | Form 4 |
| Jun 25, 2021 | STOKELY DAN CFO | Sale | 22,500 | $40K | Form 4 |
| May 21, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Option | 2,603 | $1K | Form 4 |
| May 21, 2021 | Cherevka Holli CHIEF OPERATING OFFICER | Sale | 2,603 | $5K | Form 4 |
| May 21, 2021 | COELHO PHILIP H Director | Option | 6,737 | $3K | Form 4 |
| May 21, 2021 | COELHO PHILIP H Director | Sale | 6,737 | $13K | Form 4 |
| May 17, 2021 | STOKELY DAN CFO | Option | 35,000 | $15K | Form 4 |
MARTINO MICHAEL A
CEO · Director
Date
May 24
Shares
76,890
Price
$0.29
Value
$22K
Cherevka Holli
CHIEF OPERATING OFFICER
Date
May 21
Shares
2,603
Price
$0.51
Value
$1K
Cherevka Holli
CHIEF OPERATING OFFICER
Date
May 21
Shares
2,603
Price
$2.00
Value
$5K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AMPE insider trading
AMPE insider trades
Ampio Pharmaceuticals, Inc. (AMPE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including AMPE. Over the past 12 months, 0 insiders have filed transactions with the SEC. AMPE insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ampio Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AMPE insider trading · 5 questionsThe insiders of Ampio Pharmaceuticals, Inc. (AMPE) include executives and directors such as AMPE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026